News
John Ian Young, who was on a five-year waiting list for the procedure before going under the knife at Hairmyres Hospital on ...
However, Mr Young soon began displaying worrying symptoms including "thick, lumpy and red" urine, and collapsed less than a ...
The UK government has committed to a 163.3 million euro stake in Eutelsat's 1.5 billion euro capital raise. This move ...
Eutelsat Group, which runs the OneWeb satellite internet constellation, will receive an additional investment from the U.K. government of €90 million (₹903 crore) as part of a fresh capital infusion ...
13hon MSN
John Ian Young was on a five-year waiting list for the procedure before going under the knife at University Hospital ...
University of Osaka researchers used genome editing to program mouse liver cells to produce exenatide, a weight-loss drug.
XyloCor Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapies for cardiovascular disease, announced the first patient has been dosed in the Phase 2b EXACT-2 ...
The National Pharmaceutical Pricing Authority (NPPA) has notified the retail prices of 71 formulations as per the provisions to set prices of new drugs under the Drugs Prices Control Order (DPCO), ...
Intraosseous Infusion Devices revenue is expected to grow by CAGR 6.2% from 2025 to 2032 and reach nearly USD 8.79 Bn. In 2032. From ER to EMS, intraosseous infusion is changing how we deliver urgent ...
Doctors explain whether vitamin IV therapy works, who should try a vitamin IV drip, and what risks you should know about ...
KalVista Pharma has finally received FDA approval for its oral kallikrein inhibitor sebetralstat, becoming the first ...
Indian pharma powers ahead with research on NDDS for painless, precision medicine delivery: Nandita Vijayasimha, Bengaluru Thursday, July 10, 2025, 08:00 Hrs [IST] Indian pharma i ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results